Ikko Ohara

Attenuating effect of angiotensin-(1–7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A^y/Ta mice

Ju-Young Moon, Mitsuo Tanimoto, Tomohito Gohda et al. · American Journal of Physiology-Renal Physiology · 2011 · 85 citations

Renal Inflammation, Ang Ii, Oxidative Stress +26

Levels of urinary matrix metalloproteinase‐9 (MMP‐9) and renal injuries in patients with type 2 diabetic nephropathy

Kyoichi Tashiro, Ichiro Koyanagi, Ikko Ohara et al. · Journal of Clinical Laboratory Analysis · 2004 · 66 citations · Full text

Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice

Shinji Hagiwara, Tomohito Gohda, Mitsuo Tanimoto et al. · Metabolism · 2009 · 41 citations

Obesity, Metabolic Syndrome, Energy Homeostasis +11

Effect of Combination Therapy with Angiotensin Receptor Blocker and 1,25-Dihydroxyvitamin D<sub>3</sub> in Type 2 Diabetic Nephropathy in KK-A<sup>y</sup>/Ta Mice

Ikko Ohara, Mitsuo Tanimoto, Tomohito Gohda et al. · Nephron Experimental Nephrology · 2010 · 34 citations

Pleiotropic effect of pyridoxamine on diabetic complications via CD36 expression in KK-Ay/Ta mice

Maki Murakoshi, Mitsuo Tanimoto, Tomohito Gohda et al. · Diabetes Research and Clinical Practice · 2009 · 27 citations

Inflammation, Metabolic Syndrome, Cd36 Expression +13